Which medication should a client with BPH avoid?

Ipratropium is an anticholinergic medication primarily used for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). In the context of benign prostatic hyperplasia (BPH), anticholinergics can interfere with bladder function by causing urinary retention, which can exacerbate symptoms associated with BPH. Since men with BPH often experience difficulty with urination due to prostate enlargement, the use of a medication that may worsen urinary retention is not advisable.

In contrast, medications like finasteride, tamsulosin, and tadalafil are used to treat BPH and are designed to alleviate symptoms by either reducing prostate size or relaxing the bladder neck. Thus, while considering treatments, the avoidance of medications like ipratropium is crucial to manage BPH effectively without complicating the condition.